NeoGenomics names Carolyn Starrett to its Board
NeoGenomics appointed Carolyn Starrett to its Board of Directors. Her experience in oncology data and AI strengthens the company's leadership for precision medicine growth.
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
NeoGenomics appointed Carolyn Starrett to its Board of Directors. Her experience in oncology data and AI strengthens the company's leadership for precision medicine growth.
Insulet announced Jonathan J. Mazelsky will join its Board as an independent director effective July 1, 2026. Mazelsky’s extensive background in healthcare innovation is expected t…
Darden Restaurants filed an 8-K filing to amend its corporate bylaws covering shareholder meetings, board governance, and officer roles through June 2026. This update is a standard…
HeartBeam Inc. announced a shift to technology licensing and leadership change. This strategic realignment aims to accelerate global adoption of its cardiac platform.
i-80 Gold reported election results from its 2026 annual meeting, re-electing all nominees and setting the director count to nine. The company faces a leadership transition as form…
RBC Bearings Incorporated and Dr. Michael J. Hartnett entered into an amended agreement extending his leadership role as President, CEO, and Chairman with automatic, one-year renew…
PVH Corp. filed an 8-K amending and restating its Stock Incentive Plan effective June 18, 2026. The filing outlines provisions for awards like restricted stock and stock options to…
CAVA adopted an Executive Severance Plan effective June 22, 2026. The document outlines severance benefits and compliance requirements for the Company's executive group.
Serve Robotics Inc. entered an indemnification agreement with executive Andreas Lieber. The deal is designed to mitigate legal risks and retain the individual amid increasing litig…
Oportun Financial Corp announced a cooperation agreement with Bradley L. Radoff and the Radoff Family Foundation, resulting in the withdrawal of Radoff's director nomination. This …
Bionano Genomics announced the hiring of Alex Hastie, Ph.D., as Chief Scientific Officer, effective July 20, 2026. His return signals a strategic focus on advancing optical genome …
Picard Medical appointed Chairman Richard Fang as interim CEO following the resignation of Patrick Schnegelsberg. The medical device developer is seeking a permanent replacement fo…
Tango Therapeutics appointed Robert Azelby to its Board of Directors. His oncology commercialization expertise is viewed as a strategic asset as the company advances its pipeline.
Adriano Duarte has been promoted to CFO effective July 1, 2026. This internal transition is expected to bolster financial strategy and support continued growth for the New Jersey-b…
Okta Inc. amended its 2017 Equity Incentive Plan effective June 18, 2026. The update establishes terms for equity compensation for officers, directors, and employees.
Cal-Maine Foods has appointed two independent directors, expanding its board to ten members. The move strengthens the company's governance and strategic oversight as it pursues gro…
Ben M. Palmer plans to retire by end-year 2026 following a 30-year career at the company. The Board initiated a formal search for a successor to ensure leadership continuity.
NIKE Chief Financial Officer Matthew Friend will transition to an advisory role following his departure in late August, continuing until September. His departure qualifies as a qua…
UMH Properties entered into an employment agreement with Kevin Miller to serve as Executive Vice President, Chief Financial Officer and Treasurer. This leadership change specifies …
QuidelOrtho Corp entered into an offer letter appointing Micah as Chief Financial Officer, effective July 6, 2026. The hiring of a new senior financial executive could signal stabi…